# Benef: __Disease prevention__ (PBN__Benef_915)

## Property: has_Beneficiary

* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)
* [patients](../Stakeholder/PBN__Stakeholder_31)
* [pharmaceutical companies](../Stakeholder/PBN__Stakeholder_124)

## Property: has_BenefDetails

Developing vaccines for infectious diseases prevents illness and reduces healthcare burden, leading to improved public health and economic stability.

## Property: has_BenefSource

* [ugail_social_2021](../Article/PBN__Article_186)
* [bayoudhi_overview_2021](../Article/PBN__Article_204)

## Property: has_BenefReturn

* [Enhanced safety, reduced healthcare-associated infections, improved patient outcomes.](../BenefReturn/PBN__BenefReturn_1004)
* [Investing in vaccine development leads to profit generation and contributes to public health improvements.](../BenefReturn/PBN__BenefReturn_1094)

